Company / Return on Equity (ROE)
PLIANT THERAPEUTICS, INC. Return on Equity (ROE) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-69.2%
FY2025
5-year range
-69.2% / -0.2%
FY2021-FY2025
Trend
-165.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PLIANT THERAPEUTICS, INC. reports negative total equity of -69.2% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-69.2% in FY2025 with a 3-year CAGR of -34.8%.
Declined from -48.9% to -69.2% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -34.8pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 165.6% year-over-year.
- Peak return on equity (roe) was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -4.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -69.2% | -165.6% |
| FY2024 | -26.0% | +46.7% |
| FY2023 | -48.9% | -42.2% |
| FY2022 | -34.4% | -15518.2% |
| FY2021 | -0.2% | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026